Traders were on guard after Federal Reserve Chair Jerome Powell said on Tuesday that the central bank is in no hurry to lower ...

The S&P 500 tumbled and interest rates spiked Wednesday after consumer prices rose more than expected in January, raising ...

Then, feature your greatest accomplishments and highest impact in résumé bullets. These types of change need efforts at all levels of the organization. Whether you led, were on the team ...

A share of Leeds-based Northern Superchargers will be up for grabs when sales of stakes in teams in The Hundred resume on Wednesday. Yorkshire, hosts of the franchise at Headingley, could become ...

ZURICH (Reuters) -Logitech International raised its full-year forecast on Tuesday, after reporting higher sales and profit for its important pre-holiday quarter, supported by strong demand for ...

Stay informed with our live blog covering India’s latest in politics, economy, crime, and general news. Get real-time updates ...

At a macro level, the year 2024 brought a small increase in global vehicle sales, but it was a decidedly mixed picture and the year was dominated by the underlying theme of a sector in fundamental ...

Melexis, Belgium's largest semiconductor supplier, on Wednesday forecast lower margin and sales for the first half of 2025, sending its shares to nearly five-year lows, as inventory corrections by ...

ZURICH, Jan 28 (Reuters) - Logitech International (LOGN.S), opens new tab raised its full-year forecast on Tuesday, after reporting higher sales and profit for its important pre-holiday quarter ...

For its current fiscal second quarter, Qualcomm forecast a sales range with a midpoint of $10.75 billion and adjusted profits of $2.80 per share, both above analyst estimates of sales of $10.34 ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Merck gave no explanation in its fourth-quarter earnings report for the pause, but sales of Gardasil fell 17% to $1.55 billion (approx. €1.47bn) in the final quarter of last year, mainly due to ...